ARCHIVES

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | March 16, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Staff Discusses New Guidelines for Core Grant Reviews, Comprehensiveness

July 24, 1992

Unclear Whether Clinical Trials Benefit Patients, Review Finds

February 27, 2004

FDA Approves 35 Medicines In Fiscal 2012, Eight in Cancer

December 28, 2012

Funding Opportunities

October 11, 2002

NCI Advisory Group, Other Cancer Meetings

January 30, 1976

In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three

March 12, 1976